Sphera Funds Management’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

Sphera Funds Management’s Portfolio FOMX Stock Details FOMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-242,000	Closed	-$1.2M	–	146
2017 Q1	$1.2M	Sell	242,000 -100,000	-29%	-$962K	0.23%	90
2016 Q4	$3.8M	Hold	342,000	–	–	0.96%	29
2016 Q3	$3.17M	Hold	342,000	–	–	0.52%	47
2016 Q2	$2.17M	Hold	342,000	–	–	0.56%	54
2016 Q1	$2.23M	Hold	342,000	–	–	0.48%	42
2015 Q4	$2.77M	Sell	342,000 -38,000	-10%	-$284K	0.41%	63
2015 Q3	$2.79M	Hold	380,000	–	–	0.36%	67
2015 Q2	$3.9M	Buy	380,000 +180,000	+90%	+$1.99M	0.38%	61
2015 Q1	$1.85M	Buy	+200,000	New	+$1.79M	0.19%	114

Other funds holding FOMX

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Sphera Funds Management's FOMX Position: Q2 2017 in Review

Sphera Funds Management sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q2 2017, closing a stake of 242,000 shares — an estimated $1.2M sold.

Sphera Funds Management first reported a position in FOMX in Q1 2015 and held it in 9 quarters. The position peaked at $3.9M in Q2 2015. 56 funds tracked by Wall St. Rank hold FOMX as of Q2 2017.

Sphera Funds Management reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q2 2017 after selling out during the quarter.
Sphera Funds Management sold 242,000 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q2 2017, an estimated $1.2M.
Sphera Funds Management first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q1 2015 and held it in 9 quarters.
Sphera Funds Management's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $3.9M in Q2 2015.
56 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q2 2017.

Based on Sphera Funds Management's 13F filing for Q2 2017, filed 9 Aug 2017.